Literature DB >> 32271413

MiR-20a acted as a ceRNA of lncRNA PTENPL and promoted bladder cancer cell proliferation and migration by regulating PDCD4.

X-L Zhong1, L Wang, X Yan, X-K Yang, H Xiu, M Zhao, X-N Wang, J-X Liu.   

Abstract

OBJECTIVE: Bladder cancer is the most frequent tumor of the urinary system. Despite variety of new treatment options, bladder cancer remains a main global medical problem. Our purpose was to explore the potential molecular and therapeutic targets of bladder cancer diagnosis. PATIENTS AND METHODS: The qRT-PCR was used to assess the expression of miR-20a in tissues and cell lines. Counting Cell Kit-8 (CCK-8) assay was carried out to evaluate cell proliferation. Cell migration was calculated using the transwell assay.
RESULTS: The expression of miR-20a increased and PDCD4 decreased in bladder cancer tissues compared with normal tissues. Overexpression of miR-20a promoted T24 cell proliferation and migration, while miR-20a inhibitor suppressed cell proliferation and migration. MiR-20a targeted PDCD4 to regulate its expression in T24 cells. MiR-20a is inversely related to PDCD4 and PTENPL in bladder cancer tissues. Upregulation of PDCD4 suppressed T24 cell proliferation and migration.
CONCLUSIONS: The PTENP1/miR-20a/PTEN axis was involved in the progression of bladder cancer. Our study investigated the function of miR-20a in bladder cancer and provided new insights into the treatment of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32271413     DOI: 10.26355/eurrev_202003_20660

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

Review 1.  A review on the role of PTENP1 in human disorders with an especial focus on tumor suppressor role of this lncRNA.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Nader Akbari Dilmaghani
Journal:  Cancer Cell Int       Date:  2022-06-02       Impact factor: 6.429

2.  Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis.

Authors:  Jingyao Wang; Xiqi Peng; Rongkang Li; Kaihao Liu; Chunduo Zhang; Xuan Chen; Guocheng Huang; Liwen Zhao; Zebo Chen; Yongqing Lai
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

3.  BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.

Authors:  Shu-Cheng Liu; You-Han Cao; Li-Bo Chen; Ran Kang; Zhong-Xin Huang; Xin-Sheng Lu
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

4.  Identification and verification of the pyroptosis-related prognostic signature and its associated regulatory axis in bladder cancer.

Authors:  Yaofen Tu; Xiaodi Ding; Zujie Mao
Journal:  Front Cell Dev Biol       Date:  2022-08-31

5.  MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma.

Authors:  Lisa Kinget; Eduard Roussel; Diether Lambrechts; Bram Boeckx; Loïc Vanginderhuysen; Maarten Albersen; Cristina Rodríguez-Antona; Osvaldo Graña-Castro; Lucía Inglada-Pérez; Annelies Verbiest; Jessica Zucman-Rossi; Gabrielle Couchy; Stefano Caruso; Annouschka Laenen; Marcella Baldewijns; Benoit Beuselinck
Journal:  Cancers (Basel)       Date:  2021-03-28       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.